It’s About Time
A rare convergence of breakthroughs in biotechnology and computational biology is creating one of the most compelling investment opportunities of our generation. Longevity Angels gives accredited investors curated, early-stage access to the companies leading this transformation
About the Network
The Longevity Angels are a group of investors supporting early-stage biotechnology companies developing therapies that target the underlying biology of aging.
We bring together founders in gerontology and rejuvenation medicine with individual investors who share a long-term interest in advancing human healthspan and lifespan.
Our approach emphasizes thoughtful deal selection and reasonable minimum investment sizes, enabling accredited investors of all levels to participate.
